Back |
home / stock / apri / apri message board
Subject | By | Source | When |
---|---|---|---|
DONT $SEEL https://www.massgeneral.org/news/press-release/Investigational-drug-re | TheFinalCD | investorshub | 09/21/2021 5:29:26 PM |
$SEEL Gets FDA clearance for$ SLS-005 in ALS, | TheFinalCD | investorshub | 09/21/2021 5:10:28 PM |
Ya! | trickledownfacists | investorshub | 09/21/2021 5:03:47 PM |
Pop back over $2s | trickledownfacists | investorshub | 09/21/2021 4:53:37 PM |
Big blocks.. | trickledownfacists | investorshub | 09/15/2021 3:06:05 PM |
Running | trickledownfacists | investorshub | 09/15/2021 2:49:07 PM |
Back over $2 | trickledownfacists | investorshub | 09/15/2021 2:07:42 PM |
Like it | trickledownfacists | investorshub | 09/14/2021 6:29:30 PM |
$SEEL been going down since stock offering was issued. | harr449 | investorshub | 09/14/2021 6:06:54 PM |
Peep | trickledownfacists | investorshub | 09/14/2021 7:26:36 AM |
$SEEL is the opposite of your MEME | Invest83838 | investorshub | 09/13/2021 11:39:35 PM |
it had a nice set up but looks | Nebuchadnezzar | investorshub | 09/13/2021 11:35:20 PM |
News, Short Squeeze, Breakout and More Instantly...
Apricus Biosciences Inc. Company Name:
APRI Stock Symbol:
NASDAQ Market:
Apricus Biosciences Inc. Website:
Seeking Shareholder Approval for Proposed Merger with Seelos Therapeutics, Inc. SAN DIEGO, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq: APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, reminds shareholders to vote by...
Company Merger with Seelos Therapeutics, Inc. Expected to Close in Fourth Quarter 2018 Apricus Shareholders Expected to Own ~15% of Estimated $94 Million Combined Company Valuation at Closing SAN DIEGO, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a bioph...